Editas Medicine Aktie
WKN DE: A2AC4K / ISIN: US28106W1036
05.03.2025 22:50:03
|
EDITAS MEDICINE, INC. Q4 Loss Increases, Misses Estimates
(RTTNews) - EDITAS MEDICINE, INC. (EDIT) revealed Loss for its fourth quarter that increased from the same period last year and missed the Street estimates.
The company's earnings came in at -$45.40 million, or -$0.55 per share. This compares with -$18.87 million, or -$0.23 per share, last year.
Analysts on average had expected the company to earn -$0.33 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 49.0% to $30.60 million from $60.05 million last year.
EDITAS MEDICINE, INC. earnings at a glance (GAAP) :
-Earnings: -$45.40 Mln. vs. -$18.87 Mln. last year. -EPS: -$0.55 vs. -$0.23 last year. -Revenue: $30.60 Mln vs. $60.05 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Editas Medicine Incmehr Nachrichten
11.05.25 |
Ausblick: Editas Medicine verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
04.03.25 |
Ausblick: Editas Medicine präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu Editas Medicine Incmehr Analysen
Aktien in diesem Artikel
Editas Medicine Inc | 2,10 | -0,38% |
|